DuocarMycin

DuocarMycin Suppliers list
Company Name: Shanghai Sphchem Co., Ltd.  
Tel: 021-56491756 13512199871
Email: 2819742715@qq.com
Company Name: Artis Chemistry (Shanghai) Co. Ltd.  
Tel: 86-21-60936353
Email:
Company Name: Shanghai SuperLan Chemcial Technique Centre  
Tel: 0-2022843681 15618226720
Email: chaolaichem@foxmail.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com

DuocarMycin manufacturers

DuocarMycin Basic information
Product Name:DuocarMycin
Synonyms:DuocarMycin;Duocarmycin DM free base;Methanone, [(1S)-1-(chloromethyl)-1,2-dihydro-5-hydroxy-3H-benz[e]indol-3-yl][5-[2-(dimethylamino)ethoxy]-1H-indol-2-yl]-
CAS:1116745-06-2
MF:C26H26ClN3O3
MW:463.96
EINECS:
Product Categories:
Mol File:1116745-06-2.mol
DuocarMycin Structure
DuocarMycin Chemical Properties
Boiling point 712.9±60.0 °C(Predicted)
density 1.345±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
pka9.47±0.40(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
DuocarMycin Usage And Synthesis
UsesDuocarmycin DM free base, a DNA minor-groove alkylator, is an antibody agent conjugates (ADCs) toxin. Duocarmycin DM free base is based on its characteristic curved indole structure and a spirocyclopropylcyclohexadienone electrophile to act anticancer activity[1][2].
IC 50Daunorubicins/Doxorubicins
References[1] Patil PC, et al. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents. Anticancer Agents Med Chem. 2015;15(5):616-630. DOI:10.2174/1871520615666141216144116
[2] Koch MF, et al. Structural, Biochemical, and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 Inhibition by Cytotoxic Duocarmycin Analogues. Angew Chem Int Ed Engl. 2015 Nov 9;54(46):13550-4. DOI:10.1002/anie.201505749
[3] Chen KC, et al. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue. Mol Pharm. 2013;10(5):1773-1782. DOI:10.1021/mp300581u
[4] Chen KC, Schmuck K, Tietze LF, Roffler SR. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue. Mol Pharm. 2013;10(5):1773-1782. DOI:10.1021/mp300581u
DuocarMycin Preparation Products And Raw materials
Tag:DuocarMycin(1116745-06-2) Related Product Information
Seco-Duocarmycin SA DC0-NH2 DuocarMycin MB Seco-Duocarmycin MA DuocarMycin DuocarMycin TM